Analytical Data
-
Gene name
ZBED1
- Application
-
Alternative Names
Putative Ac-like transposable elementdREF homolog
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O96006
-
Expression Region
1-210aa
-
Molecular Weight
50.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZBED1, a zinc-finger BED domain-containing protein, has emerged as a significant focus of research due to its critical role in regulating gene expression and its involvement in various biological processes. Initially identified for its ability to bind to specific DNA sequences, ZBED1 is known to influence chromatin structure and recruit transcriptional co-factors, thereby modulating the transcription of target genes. Recent studies have highlighted its importance in cellular differentiation, development, and stress responses, making it a potential player in various diseases, including cancer. Investigations into the recombinant expression and functional characterization of ZBED1 have gained momentum as researchers aim to unravel its mechanisms of action. By producing ZBED1 as a recombinant protein, scientists can conduct detailed biochemical assays to assess its DNA-binding affinity, interaction with other proteins, and impact on transcriptional regulation. This approach enables a deeper understanding of the functional dynamics of ZBED1 and its relevance in health and disease, paving the way for potential therapeutic applications. As ZBED1 continues to be studied in various model organisms, its significance in gene regulatory networks and potential as a target for drug development are becoming increasingly evident, underscoring the need for comprehensive research in this area.
